$TirzepatidePriceGuide
Cost comparison

Zepbound® vs compounded tirzepatide cost

Made with the drug in Zepbound, but two very different products. Zepbound is FDA-approved and brand-name; compounded tirzepatide is cash-pay and not FDA-approved. Here's how cost, regulation, and access compare.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
 Compounded tirzepatideZepbound®
Maker503A / 503B pharmaciesEli Lilly
FDA statusNot FDA-approvedFDA-approved (chronic weight)
Active ingredientTirzepatideTirzepatide
MechanismDual GLP-1 / GIPDual GLP-1 / GIP
From / month$115 (NexLife)*$349–$1,059
InsuranceCash-pay (HSA/FSA)Possible with coverage
Pivotal trial(not studied as a product)SURMOUNT-1 — 22.5% at 72 wk

Verified July 2026. Zepbound LillyDirect self-pay vials sit at the low end of the brand range; pharmacy retail list near the high end.

Which is right for you?

Choose brand-name Zepbound if you want an FDA-approved product and either have insurance coverage or can use Lilly's self-pay vials. Choose compounded tirzepatide if you're cash-pay and want a lower predictable monthly cost — accepting that compounded products are not FDA-approved and that quality depends on the pharmacy. Either way, a licensed clinician decides eligibility.

For the flat-rate compounded option we rank #1, see the NexLife review. For pharmacy mechanics, see 503A vs 503B.

Important. Compounded tirzepatide is not the same as Zepbound®, which is owned by Eli Lilly and Company. Compounded products are not FDA-approved.
Top pick · compounded
$115/mo*
See NexLife pricing →
Keep reading

Explore the price guide